Assignee
NEUROBO PHARMACEUTICALS INC
US·5 granted patents·5 pending applications·4 citations·filing 2015–2022
Top patents by PatentIndex Score
10 records- 0184US10588927B2Composition containing mixed extract of mulberry and Poria cocos peelNEUROBO PHARMACEUTICALS INC·Filed 2015·Granted Mar 17, 2020·3 cites·15 claims
- 0273US12503422B2Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use thereforNEUROBO PHARMACEUTICALS INC·Filed 2022·Granted Dec 23, 2025·0 cites·8 claims
- 0371US10864238B2Composition containing Poria cocos peel extract for treating neurodegenerative disordersNEUROBO PHARMACEUTICALS INC·Filed 2015·Granted Dec 15, 2020·1 cites·14 claims
- 0470US2022402854A1PROCESSES AND INTERMEDIATES FOR PREPARING alpha,omega-DICARBOXYLIC ACID-TERMINATED DIALKENE ETHERSNEUROBO PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0564US10946053B2Composition containing mixed extract of mulberry and Poria cocos bark for preventing, improving or treating neurodegenerative disordersNEUROBO PHARMACEUTICALS INC·Filed 2020·Granted Mar 16, 2021·0 cites·7 claims
- 0662US2021283206A1Composition containing mixed extract of mulberry and poria cocos barkNEUROBO PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0756US10709678B2Methods of reducing risk of cardiovascular diseaseNEUROBO PHARMACEUTICALS INC·Filed 2018·Granted Jul 14, 2020·0 cites·23 claims
- 0856US2021128656A1Composition containing poria cocos peel extract for treating neurodegenerative disordersNEUROBO PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0950US2022031642A1Niclosamide Formulations and Methods of UseNEUROBO PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1048US2020253877A1Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use thereforNEUROBO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEUROBO PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →